Influenza Splited vaccine (ShanXi Peisen)

流感病毒裂解疫苗（山西培森）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInfluenza Splited vaccine (ShanXi Peisen)
Drug Alias NameSeasonal influenza virus vaccine - AdimmuneAdimflu-S Children
ClassificationVaccines > National Immunization Program > Non-immunization program vaccine(Class II)Vaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza, HumanCommon Cold
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanxi Peisen Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanxi Peisen Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsInfluenza, HumanCommon Cold
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A